CORNING. N.Y. — Corning Incorporated (NYSE: GLW) today announced that its vice chairman and corporate development officer, Lawrence D. McRae, who has been with the company for nearly four decades, will retire at the end of the year. McRae will continue in his current role and remain on Corning’s Senior Leadership Team until his retirement. “Larry has […]
The Schauenburg Analytics Group (Markes International & SepSolve Analytical) is pleased to announce the appointment of Nigel Fry as its Chief Executive Officer (CEO). As of September 2023, Fry became responsible for all aspects of the business operations of Schauenburg Analytics Ltd and its subsidiaries, Markes International Ltd and SepSolve Analytical Ltd. Fry joins the […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mark Buck as senior vice president, operations. Mr. Buck brings experience improving manufacturing efficiency and driving revenue and margin through managing supply chain and operations, including planning, quality, […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE […]
Appointment of Vincent Smith, PhD, as Chief Technology Officer and Jessica Rich as VP Business Development Follows Broken String’s successful $15M Series A fundraising round in September 20231 Will support development and commercialization strategy for INDUCE-seq DNA break-mapping platform Cambridge, UK — Broken String Biosciences (“Broken String”), a genomics company building a technology platform to […]
Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024. Over the Q4 2023 period, Gerry will transition into his new role working with Jonathan Flint, Executive Chairman and the Leadership Team at Refeyn. Gerry brings extensive […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Jordan Laser has received the AMP Meritorious Service Award from the Association for Molecular Pathology (AMP). Dr. Laser is receiving this honor to recognize his dedication and effort behind the scenes to position AMP as the premier molecular diagnostics professional association around the world. Dr. […]
Today, LGC announced the appointment of David P. King as Non-Executive Chairman of its Board of Directors. Euan O’Sullivan, President & Chief Executive Officer (CEO) of LGC said: “We are delighted to welcome David to LGC’s Board of Directors, given his extensive healthcare experience within the diagnostics, pharmaceutical and biotech sectors, key customer focus areas […]
Industry Veteran Herman Cueto Named CFO Azenta CFO Lindon Robertson to Retire Company Reaffirms Guidance for Fourth Quarter Fiscal 2023 BURLINGTON, Mass., Sept. 26, 2023 Azenta, Inc. (Nasdaq: AZTA) today announced that Herman Cueto will join Azenta as Executive Vice President and Chief Financial Officer, effective October 16. Mr. Cueto, who comes from BD (Becton, Dickinson and Company, NYSE: BDX), will succeed […]
Avantor® Announces Ger Brophy to Retire in 2024; Benoit Gourdier Appointed EVP, Biopharma Production
RADNOR, Pa., Sept. 26, 2023 – Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, today announced that Benoit Gourdier will join the company as EVP, Biopharma Production on October 2, 2023. Mr. Gourdier will succeed Dr. Ger Brophy, who will retire from […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
